-
Symbol
-
CTNM on Nasdaq
-
Investment type
-
Equity / Class A Common Stock, $0.001 par value per share
-
Latest Disclosed Shares Owned
-
699,486 shares
-
Security Ownership %
-
3.2%
Shares, Excluding Options vs Price
Perceptive Advisors LLC ownership in Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (CTNM)
14 Aug 2025 - Perceptive Advisors LLC has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 699,486 shares of Contineum Therapeutics, Inc. Class A Common Stock, $0.001 par value per share (CTNM).
This represents 3.2% ownership of the company.
In their previous filing dated 15 May 2025, PERCEPTIVE ADVISORS LLC had reported owning 1,441,249 shares, indicating a decrease of +51%.
.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.